Jolynn Knoche Sessions, Pharm.D, BCOP

Transcription

1 Jolynn Knoche Sessions, Pharm.D, BCOP Home: Office: 596 Garren Creek Road Mission SECU Cancer Center Fairview, North Carolina Hospital Drive Home: Asheville, North Carolina Cell: Office: Fax: Licensure and Certification North Carolina # June 1995 to present Florida # January Georgia # August 1997 to 2008 Board Certified Oncology Pharmacist (BCOP) # December 2002 to present North Carolina Clinical Pharmacist Provider (CPP ) - February May 2014 and associated DEA registration Professional Experience 6/14-present Oncology Clinical Pharmacy Faculty Mission Hospital and UNC Eshelman School of Pharmacy Associate Professor of Clinical Education Asheville, North Carolina 5/08-6/14 Oncology Clinical Pharmacist Specialist Director of ESA-anemia clinic Charles George Veterans Administration Department of Pharmacy Asheville, North Carolina 4/12-present Mission Hospitals Outpatient Pharmacy PRN pharmacist 3/01-6/08 Clinical Coordinator of Hematology/Oncology Clinical Pharmacy Services and Clinical Pharmacist Director, Oncology Pharmacy Practice Residency Program Emory University Hospital Department of Pharmacy

2 Atlanta, Georgia 6/99-3/01 Hematology/Oncology Clinical Pharmacist Emory University Hospital Department of Pharmacy Atlanta, Georgia 1/99-7/03 Associate Faculty Atlanta Area Facilitator University of Florida College of Pharmacy Working Professional Pharm. D. Program (WPPD) Tampa, Florida 8/97-6/99 Hematology/Oncology Clinical Pharmacist Specialist Grady Health System Department of Pharmacy & Drug Information Atlanta, Georgia 7/96-7/97 ASHP-Accredited Specialty Residency in Oncology Pharmacy Practice UT M.D. Anderson Cancer Center Houston, Texas Residency Director: Judy Chase, Pharm.D. 7/95-6/96 ASHP-Accredited Pharmacy Practice Residency North Carolina Baptist Hospitals, Inc. Bowman Gray/Baptist Hospital Medical Center Winston-Salem, North Carolina Residency Director: Maryann Restino, Pharm.D., BCPS 5/92-6/95 Pharmacy Intern/Technician H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida Tampa, Florida 1/90-4/94 Pharmacy Intern/Technician University of Florida Student Health Services Pharmacy Gainesville, Florida Education 8/91-5/95 Doctor of Pharmacy University of Florida College of Pharmacy Gainesville, Florida 7/89-8/91 Pre-pharmacy

3 University of Florida Gainesville, Florida Professional Involvement Hematology Oncology Pharmacy Association (HOPA) Member since inception in 2004 ACPE (CE) committee member Vice-chair Chair Treasurer Board of Directors Chair of Budget Committee Board Liaison of Research Committee Board Liaison of Research Abstract Review Workgroup North Carolina Oncology Pharmacist Association (NCOP) member since 2009 American Association of Colleges of Pharmacy member 2014-present. Mission Health System Cancer Investigational Review Board Member 9/2014- present. Mission Cancer Program Regimen Review Committee (Inpatient and Outpatient Committees) 6/2014-present. Mission Cancer Program Clinical Oversight Committee. 11/2014-present. Charles George Veterans Administration Cancer Committee. 6/2008-6/2014 Commission on Cancer Accreditation sub-committee co-chair. Charles George Veterans Administration Pain Committee. 6/2008-6/2014 Winship Cancer Center Standard Orders Committee (SOC)- Co-chairman. 8/03-5/08. Committee is responsible for the development, standardization, review and safety of chemotherapy and other therapy for oncology patients at Emory Healthcare. Oncology clinical pharmacy group develops all order sets. Winship Cancer Center Research Orders Committee (ROC) - Founding member. Committee is responsible for the development, standardization, review and safety of chemotherapy and other therapy for oncology patients at Emory Healthcare. Oncology clinical pharmacy group develops all Winship Cancer Center research order sets.

4 Emory University Hospital Cancer Committee Member. 4/01-5/08. Winship Cancer Institute Education Consortium 7/03-5/08 Clinical Research Review Committee of the Winship Cancer Institute. Member and Reviewer. 4/01-3/06. Winship Cancer Institute Patient Care Consortium Pain Standards Subcommittee Co-chairman. 11/00-10/02. Emory Bone Marrow and Stem Cell Transplant Service Quality Improvement Committee. 9/00 5/08. Atlanta Academy of Institutional Pharmacists. Member 11/97 5/08. American Society of Health-Systems Pharmacists. Member , Grady Health System Hospice Interdisciplinary Team. February /99. Academic Appointments University of North Carolina Eshelman School of Pharmacy Associate Professor of Clinical Education, PACE Division. 6/2014 to present. University of North Carolina Eshelman School of Pharmacy Adjunct Faculty. Preceptor of Doctorate of Pharmacy students for outpatient oncology rotation at the Charles George VA Medical Center Wingate University School of Pharmacy Adjunct Faculty. Preceptor of Doctorate of Pharmacy students for outpatient oncology rotation at the Charles George VA Medical Center University of Florida Associate Faculty Atlanta Area Facilitator for the Working Professional Pharm. D. Program (WPPD) University of Georgia Adjunct Faculty. Preceptor of Doctorate of Pharmacy students for Leukemia/Hematology, Stem Cell Transplant and Oncology rotations at Emory University Hospital and the Winship Cancer Institute. 6/99-5/08 Mercer College of Pharmacy Adjunct Faculty. Preceptor of Doctorate of Pharmacy students for Leukemia/Hematology, Stem Cell Transplant and Oncology rotations at Emory University Hospital and the Winship Cancer Institute. 1/98 5/08.

5 Academic Teaching and Involvement PHCY447 Pharmacotherapy: hematology and oncology. University of North Carolina Eshelman School of Pharmacy. Acute Leukemias lecture 11/3/2014. Lead 2 recitations for this course Hodgkin's and Non-Hodgkin's Lymphoma. Wingate University School of Pharmacy. Lecture to 3 rd year pharmacy students. 2010, 2011, 2012, Hodgkin s and Non-Hodgkin s Lymphoma. Pharmacotherapy I Class (Phrm 5860). University of Georgia College of Pharmacy. 11/1/99, 11/6/00, 10/22/01, 10/21/02, 11/3/03. Breast Cancer Lecture 2 hour block. PHA 557 Hematology and Oncology Disorders. Mercer College of Pharmacy, Atlanta, Georgia. Spring 2004, 2005, 2006, Nursing Residency Program. Review of Drug Classes. Taxanes, Immunomodulators and Monoclonal Antibodies, Antimetabolites and Hormonal Agents, Extravasation Procedures, Nausea and Vomiting. Lectures given two to four times a year from 2000 to 4/2008. Chemotherapy Pharmacology Lecture Series. Emory University, Atlanta, Georgia. First, Second, and Third year Hematology/Oncology Fellow Physicians. Lecture topics: geriatric oncology pharmacology, topoisomerase inhibitors, taxanes, overview of commonly used chemotherapy regimens., immunosuppressants in HSCT October /2008. Colorectal Cancer. University of Houston College of Pharmacy, Houston, Texas. Third-year Doctor of Pharmacy Students. April 22, Continuing Education Lectures (ACPE and/or CME accredited) and Invited Presentations Improving Outcomes in CML: A 2014 Update for Managed Care Healthcare Professionals. Webcast presented on 6/5/2014 and 6/10/2014 CML Debate: Beyond first line therapy. At tenth annual HOPA (Hematology Oncology Pharmacy Association 2012 conference. March 26, L01-P

6 Oncology Pharmacy Bootcamp: GI Toxicities of Chemotherapy. Part of National VA virtual training series. July 23, Lung Cancer Update: screening and novel treatments. Charles George VA Medical Center, December 5, Presented with oncologist James Puckett, MD. 1 hour of AMA PRA category 1 CME. Nausea and Vomiting Control in Multi-day Chemotherapy in Clinical Pearls and Interesting Cases. At the annual North Carolina Oncology Pharmacist Meeting (NCOP). August 11, L01-P Prostate Cancer Update. Charles George VA Medical Center. January 18, Presented with oncologist James Puckett, MD. 1 hour of AMA PRA category 1 CME. Controversies in Care: Hematology. Chronic Myelogenous Leukemia: Dasatinib Dosing & Monitoring at eighth annual HOPA (Hematology Oncology Pharmacy Association 2012 conference. March 22, 2012 The Evolving Management of Chronic Myeloid Leukemia: Pharmacist Considerations. Live Interactive webcasts on July 13 th, 26 th and August 3 rd, L01P New Drug Update. At the annual North Carolina Oncology Pharmacist Meeting. August 14, L01P Chronic Myelogenous Leukemia: Evolving Treatment Strategies. At sixth annual HOPA (Hematology Oncology Pharmacy Association 2010 conference. March 25 th H01P New Drug Update. At the annual North Carolina Oncology Pharmacist Meeting. August 15, L01P To Nib or to Cut? Hepatocellular Carcinoma Update Board Certification Oncology Pharmacist Lecture At the fifth annual HOPA (Hematology Oncology Pharmacy Association) 2009 Conference. June 18, L01P Clinical Pearls Cutaneous side effects from EGFR inhibitors. North Carolina Association of Pharmacists Acute Care Practice Forum Spring Meeting. March 25, L04-P ASCO update Update of the 44 th annual meeting of the American Society of Clinical Oncology. At the fourth annual HOPA (Hematology Oncology Pharmacy Association) 2008 conference. June 21, L04-P

7 Nursing Residency Program. Review of Drug Classes. Taxanes, Immunomodulators and Monoclonal Antibodies, Antimetabolites and Hormonal Agents, Extravasation Procedures, Nausea and Vomiting. Lectures given two to four times a year from 2000 to 4/2008. Chemotherapy Pharmacology Lecture Series. Emory University, Atlanta, Georgia. First, Second, and Third year Hematology/Oncology Fellow Physicians. Lecture topics: geriatric oncology pharmacology, topoisomerase inhibitors, taxanes, overview of commonly used chemotherapy regimens., immunosuppressants in HSCT October /2008. ASCO update Update of the 43 rd annual meeting of the American Society of Clinical Oncology. At the third annual HOPA (Hematology Oncology Pharmacy Association 2007 conference. June 15, L01 Immunosuppressants in Hematopoietic Stem Cell Transplant (HSCT): Focus on Graft versus Host Disease (GVHD) prophylaxis. Emory Healthcare Department of Pharmacy. May 18 and 22, 2007 Optimizing outcomes through pharmaceutical advances in the treatment of chronic myeloid leukemia: Chronic myeloid leukemia in At the Academy of Managed Care Pharmacy (AMCP) annual meeting. April 12, L01 Translating Pharmaceutical Advancements for CML into Improved Patient Responses: Monitoring your Patients with Chronic Myeloid Leukemia. At Hematology Oncology Pharmacy Association (HOPA) 2006 Second Annual Meeting. June 15, The Basics of Chemotherapy: Asking the Right Questions. Crawford Long Hospital Department of Pharmacy, Atlanta, Georgia. April 30 and May Pharmacist Involvement in Pain Management: Step 1. Emory University Hospital Department of Pharmacy, Atlanta, Georgia. October 23, New Modalities in Cancer Treatment: Monoclonal Antibodies. Emory University Hospital, Atlanta, Georgia. August 23 & 24, Identifying, Monitoring, and Managing Drug-Drug Interactions. Emory University Hospital, Atlanta, Georgia. April 12 & 13, The Nuts & Bolts of Pain Management. Grady Health System Pharmacy Grand Rounds. May 19, 1998.

8 Challenges in Oncology: Chemotherapy Drug Resistance. Continuing Education Presentation for Pharmacists. North Carolina Baptist Hospital, Winston-Salem, North Carolina. May 7 & 14, Additional Select Lectures and Presentations The 4 P s of Pain: Pharmacologic Interventions. Charles George VA Pain Symposium. To physicians, physician assistants, nurse practitioners, pharmacists, and nurses. October 9 and 10, Chemotherapy-Induced Nausea and Vomiting (CINV): A Review of the Epidemiology and Pathophysiology. For Emory Healthcare oncology nursing and pharmacy staff. 11/20/02 4/2008. Pain Medications and Steroids, for Brain Tumor Support Group. March 2, 2006 Nelarabine (Arranon): New Agent for Refractory T-cell Disease. Presented at the Winship Cancer Institute Hematology Multi-Disciplinary Conference, November 10, 2005 Clinical Applications of Targeted Agents in Hematological Malignancies. Georgia Advance Practice Oncology Symposium. Sponsored by the Winship Cancer Institute. March 27, 2004 Pain Management in Multiple Myeloma. Presented at the Multiple Myeloma Regional Support Group Symposium. August 15, 2003 Narcotic and Non-narcotic Analgesics. Medical-Surgical Nursing Pharmacology Lecture. Grady Health System. June 25, Brain Tumors. Pharmacy Oncology Forum. UT M.D. Anderson Cancer Center, Houston, Texas. June 19, Efficacy of Anastrozole (Arimidex) in a consecutive series of advanced breast cancer patients: M.D. Anderson Cancer Center Experience. 23 rd Annual Midwest Pharmacy Residency Conference, Memphis, Tennessee. April 18, Taxanes. Pharmacy Oncology Forum. UT M.D. Anderson Cancer Center, Houston, Texas. April 16, Tumor Vaccines - Fact or Fiction. Pharmacy Grand Rounds at UT M.D. Anderson Cancer Center. February 6, 1997

9 Colony Stimulating Factors. Pharmacy Oncology Forum. UT M.D. Anderson Cancer Center, Houston, Texas. December 19, Pharmacology of Antineoplastics. Pharmacy Oncology Forum. UT M.D. Anderson Cancer Center, Houston, Texas. September 26, Principles of Chemotherapy. Pharmacy Oncology Forum. UT M.D. Anderson Cancer Center, Houston, Texas. September 12, Chemotherapy-induced Nausea and Vomiting. Pharmacy Oncology Forum. UT M.D. Anderson Cancer Center, Houston, Texas. August 1, Opiates. Bowman Gray College of Medicine, Winston-Salem, North Carolina. Physicians Assistant Pharmacology Course. March 6, Pain Management in the Elderly. The University of North Carolina - Greensboro. Gerontological Pharmacotherapeutics for Nurse Practitioners Course. October 19, Publications Sessions JK, Valgus J, Barbour SY, Iacovelli L. Role of Oncology Clinical Pharmacists in Light of the Oncology Workforce Study. Journal of Oncology Practice 2010;6(5): Stricker S, Sessions J. Beyond Chemotherapy: Non-Hodgkin s Lymphoma Update in The Oncology Nurse/The Oncology Pharmacist, May 2009 Vol.2, No 3, Sessions J. Chronic Myeloid Leukemia in 2007 Am J Health-Syst Pharm. 2007; 64(Suppl 15):S4-9 Frame D, Sessions J, Fausel C. Q&A Highlights. Am J Health-Syst Pharm. 2007; 64(Suppl I5):S22 Sessions J. Chronic Myeloid Leukemia in Journal of Managed Care Pharmacy Supplement October 2007 Vol. 13, No. 8, S4-7

10 Santos EC, Sessions J, Hutcherson D, Flowers C, Langston A, Waller EK. Comment on: Long-term outcome of Hodgkin disease patients following highdose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation a similar experience. Biology of Blood & Marrow Transplantation Jun 13(6)746-7 Sessions, J. Monitoring your patients with chronic myeloid leukemia. American Journal of Health-System Pharmacy 2006; 63(Suppl 8):S5-9. Sessions, JK. UHC (University Healthsystem Consortium) Drug Monograph:Oregovomab October2004 Sessions JK, Hutcherson D, Shayani S, et. al. Assessment of delayed nausea and vomiting control in cyclophosphamide-based preparative regimens for hematopoietic progenitor cell transplant. Proc American Society of Clinical Oncolgy 22:page 791, 2003 (abstract 3179) Redei I, Knoche J, Tanner A, et al. Salvage therapy with infliximab for patients with severe and chronic GvHD. Proc. ASH 2001, (Abstract 1678). Mihelic RA, Walton SM, Hutcherson DA, Knoche AJ. Evaluation of single-dose oral ondansetron vs. oral granisetron for prevention of chemotherapy-induced nausea and vomiting due to high-dose chemotherapy. Proc ASCO 2000;19:631a(abstract 2487). Knoche AJ. Chapter 29: Nausea and Vomiting. In Pharmacotherapeutics for Advanced Practice: A Practical Approach, 1 st edition. Arcangelo V, Peterson A. editors. Lippincott Williams & Wilkins Publishers, Philadelphia, PA Michaud LB, Knoche AJ, Abbott B, Buzdar AU, and Tashima C. Efficacy of Anastrozole (Arimidex) in a consecutive series of advanced breast cancer patients: M.D. Anderson Cancer Center Experience. American Society of Clinical Oncologists Abstract Research Sessions J, Puckett JB, Peek B. Impact of Oncology Clinical Pharmacist with Scope of Practice in a VA Oncology Clinic. Poster presentation at AVAHO (Association of VA Hematology Oncology). Portland, Oregon. September Barker V, Sessions J, Evaluation of the safety, tolerability, and financial implications of rapid-infusion rituximab in a hospital-based infusion center. ASHP Midyear in-process poster presentation 2014.

11 Sessions J, Patterson D, Laughter D. Correct Level of Care: Optimizing Oncology Care at the Charles George VAMC. Poster presentation at AVAHO (Association of VA Hematology Oncology). September Sessions J, Peek B, Combs J. Process for Comparing Oncology Practices. Poster presentation at AVAHO (Association of VA Hematology Oncology) September 9, Mihelic R, Hutcherson D, Sessions J, Haas M, Hutcherson D, Langston A, Winton E, Modified HDAC and DNR (6+3) as Remission Induction Therapy for Newly Diagnosed Patients With Acute Myelogenous Leukemia (AML). Completed at Emory University Hospital (Atlanta, Georgia). Findings presented at The 2004 American Society of Health-System Pharmacists Midyear Clinical Meeting Haas M, Hutcherson DA, Mihelic RA, Sessions JK. Caspofungin Use in an Oncology Patient Population: Survival Outcomes, Mycologic Response, and Safety Profile. Poster presentation #69. American Society of Health-systems Pharmacists Midyear Clinical Meeting New Orleans, La. Bean SA, Knoche AJ, Walton, SM, and Hutcherson DA. Double blind comparison of morphine to meperidine for the treatment of amphotericin B induced chills and rigors. 32 nd Annual Southeastern Residency Conference. Athens, Georgia. April 26, 2001 Efficacy of Anastrozole (Arimidex) in a consecutive series of advanced breast cancer patients: M.D. Anderson Cancer Center Experience. Collaborative authors: Michaud LB, Knoche AJ, Abbott B, Buzdar AU, and Tashima C. UT M.D. Anderson Cancer Center, Houston, Texas. October August Projects Y-site compatibility chart for commonly used oncology drugs. Emory University Hospital. February Grady Health System Department of Hematology & Oncology Taxol Premedication Policy and Procedure. Approved by the Departments of Hematology and Oncology December Grady Health System Patient Controlled Analgesia (PCA) Medication Use Evaluation. 1/97-8/97. Grady Health System Antiemetic Guidelines for Chemotherapy-induced Nausea and Vomiting in Adult Patients. Approved by Drug Use and Effects Committee November Approved by Pharmacy & Therapy Committee December 1998.

12 Grady Health System Guidelines for the Handling of Cytotoxic and Hazardous Drugs (revision). Approved by the Department of Pharmacy May Grady Health System Hematology/Oncology Chemotherapy Pre-printed Physician Order Forms. Approved by the Departments of Hematology, Oncology, and Grady Health System Forms Committee. March, Outcome assessment of early conversion from IV to PO - focus on ciprofloxacin and fluconazole. North Carolina Baptist Hospitals, Inc. Winston-Salem, North Carolina. August 1995-June Revised 1/2015